16. Subsequent Events |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2020 | |||
| Subsequent Events [Abstract] | |||
| Subsequent Events |
The Company performed a review of events subsequent to the balance sheet date through the date the financial statements were issued and determined that, other than the Pharmsynthez Loan Extension discussed in Note 7, Goodwill, Indefinite-Lived Intangible Assets and Other Long-Term Assets, there were no such events requiring recognition or disclosure in the financial statements. |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|